Bion Occipital Nerve Stimulation (ONS) Compassionate Use Study
Compassionate Use Study of the Bion for Occipital Nerve Stimulation for Treatment of Chronic Headaches
2 other identifiers
observational
11
1 country
2
Brief Summary
The purpose of this compassionate use study is to provide clinical and technical support of the Bion® microstimulator system to the subjects who have decided to keep the system for relief of headache symptoms that have not responded to medical treatment. These study subjects were enrolled and implanted with the Bion® system during a previous clinical investigation of the Bion® for occipital nerve stimulation (ONS) in the United States.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2010
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
January 14, 2010
CompletedFirst Posted
Study publicly available on registry
January 18, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2011
CompletedNovember 13, 2020
November 1, 2013
1.2 years
January 14, 2010
November 12, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Provision of one year of clinical and technical support
This is a compassionate use study. There are no primary outcome measures.
Interventions
Eligibility Criteria
Subjects who were enrolled and implanted with the Bion® system during a prior feasibility clinical investigation of the device for occipital nerve stimulation (ONS) in the United States.
You may qualify if:
- Subject participated in a prior clinical feasibility study of the Bion for occipital nerve stimulation in the treatment of chronic headaches (IDE G030225) and remained implanted with the Bion system.
- Subject elects to enroll in this compassionate use study and provides written informed consent.
- Subject understands the type and duration of clinical, technical or product support provided in the study.
- Subject is willing to comply with protocol-required activities.
You may not qualify if:
- Subject is currently participating or intends to participate in another investigational drug or device clinical trial for chronic headaches during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
Michigan Head Pain & Neurological Institute
Ann Arbor, Michigan, 48104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Roshini Jain
Boston Scientific Neuromodulation Corporation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 14, 2010
First Posted
January 18, 2010
Study Start
January 1, 2010
Primary Completion
April 1, 2011
Study Completion
April 1, 2011
Last Updated
November 13, 2020
Record last verified: 2013-11